• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC, INC. CRYOFLEX SURGICAL ABLATION PROBE; SURGICAL DEVICE, FOR CUTTING, COAGULATION, AND/OR ABLATION OF TISSUE, INCLUDING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC, INC. CRYOFLEX SURGICAL ABLATION PROBE; SURGICAL DEVICE, FOR CUTTING, COAGULATION, AND/OR ABLATION OF TISSUE, INCLUDING Back to Search Results
Model Number 60SF3
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Complete Heart Block (2627)
Date of Event 11/23/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
During the procedure ((b)(6) 2018), a cyroflex probe and cardioblate bipolar clamp were used through sternotomy to treat the patients af.Left pulmonary vein (pv) and right pulmonary vein (pv) conduction block achieved.The patient had a concomitant surgical procedure of mitral valve replacement and amputated/excised and oversewn.Approximately 7 days post procedure the patient experienced complete heart block requiring a permanent pacemaker.The patient received a pacemaker.Patient was discharged 13 days post procedure ((b)(6) 2018) with sinus rhythm.The adverse event was deemed as been not related to the device but possibly related to the study and concomitant procedure.Need for a pacemarker implantation is a known complication to surgical ablation and mitral valve replacement.The patient had a concomitant surgical procedure of mitral valve replacement and amputated/excised and oversewn.
 
Additional Manufacturer Narrative
Additional information: a.Patient information 4.Weight in kgs.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CRYOFLEX SURGICAL ABLATION PROBE
Common Device Name
SURGICAL DEVICE, FOR CUTTING, COAGULATION, AND/OR ABLATION OF TISSUE, INCLUDING
Manufacturer (Section D)
MEDTRONIC, INC.
3800 annapolis lane
minneapolis MN 55447
Manufacturer (Section G)
MEDTRONIC, INC.
3800 annapolis lane
minneapolis MN 55447
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key8173453
Report Number3008592544-2018-00069
Device Sequence Number2792613
Product Code OCL
UDI-Device Identifier00643169183865
UDI-Public00643169183865
Combination Product (Y/N)N
Initial Reporter StateMO
Initial Reporter CountryUS
PMA/510(K) Number
K123733
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Reporter Type Manufacturer
Report Source Study,Health Professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 11/22/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date02/19/2020
Device Model Number60SF3
Device Catalogue Number60SF3
Device Lot Number05018008
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/04/2018
Supplement Date Received by Manufacturer11/21/2024
Initial Report FDA Received Date12/18/2018
Supplement Report FDA Received Date11/22/2024
Date Device Manufactured03/19/2018
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age78 YR
Patient SexFemale
Patient Weight91 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-